Today: 19 May 2026
Browse Category

SGX:S63 17 January 2026 - 16 April 2026

Singapore Stock Market Today: STI Slips Despite Asia Rally as Banks Drag, Olam Jumps

Singapore Stock Market Today: STI Slips Despite Asia Rally as Banks Drag, Olam Jumps

Singapore’s Straits Times Index fell 0.27% to 5,007.83 on Thursday, weighed by declines in DBS, OCBC, UOB, and Singtel. Olam surged nearly 8% after clearing the last hurdle for its Olam Agri sale. The STI lagged regional peers as Japan’s Nikkei 225 and Hong Kong’s Hang Seng both advanced. Singapore’s economy remains sensitive to higher import costs and supply disruptions despite recent GDP growth.
ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
ST Engineering stock rises in Singapore as MRO upgrade and satellite plans keep earnings in focus

ST Engineering stock rises in Singapore as MRO upgrade and satellite plans keep earnings in focus

ST Engineering shares rose 1.2% to S$9.92 in Singapore afternoon trading after announcing expanded aircraft maintenance services and new satellite projects. The company unveiled a larger unmanned cargo drone at the Singapore Airshow and plans to launch a laser-communications satellite in late 2026. Full-year results are due before market open on Feb. 27.
3 February 2026
ST Engineering stock price ticks higher on record S$18.7b contract wins — what traders watch next

ST Engineering stock price ticks higher on record S$18.7b contract wins — what traders watch next

ST Engineering shares rose 0.3% to S$9.47 after reporting record FY2025 contract wins of S$18.7 billion, including S$4.7 billion in the fourth quarter. Broker CGS International raised its target price to S$10.20, citing new defence contracts. FY2025 results are due Feb 27. The company said recent contract wins will not significantly affect current-year earnings.
ST Engineering (S63) share price inches up in Singapore as MAS decision and Airshow loom

ST Engineering (S63) share price inches up in Singapore as MAS decision and Airshow loom

ST Engineering shares rose 0.3% to S$9.39 in afternoon trading Monday, near their 52-week high. The Monetary Authority of Singapore will review policy Thursday, with most analysts expecting no change. ST Engineering recently signed a five-year nacelle maintenance deal with LOT Polish Airlines and repurchased 500,000 shares last week. The company will showcase at the Singapore Airshow in early February.
26 January 2026
ST Engineering stock slips 1.7% in Singapore as Qatar services deal and $151B U.S. contract hit the tape

ST Engineering stock slips 1.7% in Singapore as Qatar services deal and $151B U.S. contract hit the tape

ST Engineering shares fell 1.7% to S$9.41 Thursday afternoon, despite new contract announcements. Barzan Holdings of Qatar signed a QAR 1.5 billion services deal with the group at DIMDEX 2026. ST Engineering’s iDirect Government unit won a U.S. Missile Defense Agency framework contract with a $151 billion ceiling. Trading volume rose, with shares moving between S$9.35 and S$9.65.
22 January 2026
ST Engineering (S63) share price drops in Singapore trade as Airshow 2026 nears, FY2025 results loom

ST Engineering (S63) share price drops in Singapore trade as Airshow 2026 nears, FY2025 results loom

ST Engineering shares fell 1.3% to S$9.51 by mid-afternoon Tuesday, after closing at S$9.64 on Monday. The move follows a technical pullback as traders watch for the Singapore Airshow starting Feb. 3 and the company’s FY2025 results on Feb. 26. The stock remains near its 52-week high and above average analyst targets. Investors are monitoring the company’s order book and the fallout from last year’s S$667 million impairment.
ST Engineering stock price hits record high — what investors watch next on SGX

ST Engineering stock price hits record high — what investors watch next on SGX

ST Engineering shares closed at a record S$9.60 on Friday, up 0.73% for the day and 103% over the past year. DBS Group Research raised its target price to S$10.20, citing predictable earnings and strong demand in defence and aviation. The company’s next earnings report is set for Feb. 26, 2026. Investors are watching for new contract announcements and 2026 guidance.
1 2 3

Stock Market Today

  • GF Securities Raises Nvidia Price Target to $308 Ahead of Earnings
    May 19, 2026, 10:00 AM EDT. GF Securities raised its price target on Nvidia to $308 from $292 ahead of the chipmaker's fiscal first-quarter earnings, citing Nvidia's strong cash position and potential share buybacks. Analyst Jeff Pu noted a slight shift in the Rubin platform timeline but maintained the 2300W spec. The firm expects Nvidia to grow its data-center silicon market share with products like Vera CPU and LPX, and possibly launch an inferencing-focused GPU. While fiscal 2027 earnings estimates remain steady, fiscal 2028 forecasts rose by 13% due to anticipated higher Blackwell shipments and pricing, partially offset by lower Rubin unit assumptions.

Latest articles

Bakkt Up Early After Director Buys $4.85M in Shares

Bakkt Up Early After Director Buys $4.85M in Shares

19 May 2026
Bakkt shares jumped 14.2% to $9.96 in pre-market trading Tuesday after a filing showed director Michael Alfred’s vehicle bought $4.85 million in stock. SEC documents said Alfred acquired 585,000 shares last week via Alpine Fox LP. CEO Akshay Naheta exercised options for 33,557 shares at $10 each. Bakkt recently reported Q1 revenue of $243.6 million, down sharply from a year earlier.
Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

19 May 2026
Relay Therapeutics shares jumped 11.3% to $13.47 in premarket trading Tuesday after reporting a 60% volumetric response rate in 20 evaluable patients from its Phase 2 trial of zovegalisib for vascular anomalies. The company said 95% of patients saw some lesion reduction at 12 weeks. No patients discontinued due to adverse events. The regular Nasdaq session was set to open at 9:30 a.m. ET.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Go toTop